A newly identified genetic marker could potentially predict which patients are likely to respond to immunotherapy in cancer types that have lacked such tools until… Read more
Category: UPMC Hillman Cancer Center
Continuing a Legacy of Excellence
As one 25-year tenure with UPMC concludes, two veteran UPMC leaders are stepping into expanded executive leadership roles, alongside a team focused to deliver UPMC’s… Read more
Breaking New Ground: Constructing the First UPMC Hillman Cancer Center in Croatia
“Today marks the start of a journey toward progress, innovation and new access to life-saving medicine for more people, close to their homes,” said Chuck… Read more
Spooky Spirit, Adding Flavor, 20 Years of Support, Decontamination | NOW EP089
Our 89th installment of UPMC NOW highlights the spirit of UPMC Children’s through costumes, crafts, and fun; a partnership between the Pittsburgh Steelers, UPMC Hillman… Read more
Cancer Drug That Targets Two Immune-Evading Tumor Tactics Performs Well in Early Clinical Trial
A “two-for-one” cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scientists from UPMC Hillman Cancer Center who led an… Read more